<DOC>
	<DOC>NCT02706743</DOC>
	<brief_summary>The aim of this study was to assess the impact of adjuvant radioactive iodine therapy on the quality of life(QOL) in differentiated thyroid cancer patients and to identify independent factors affecting changes in the QOL.</brief_summary>
	<brief_title>Assessment of Quality of Life After Adjunct Radioiodine Therapy in Patients With Differentiated Thyroid Cancer</brief_title>
	<detailed_description />
	<mesh_term>Thyroid Diseases</mesh_term>
	<mesh_term>Thyroid Neoplasms</mesh_term>
	<criteria>Pathologically confirmed new diagnosis of differentiated thyroid cancer, recently treated by total thyroidectomy Must sign a consent form before treatment One year or more of followup after radioiodine ablation Patients with follicular, HÃ¼rthle cell, poorly differentiated, medullary, or anaplastic thyroid carcinoma Pregnant or lactating women Patients that received adjuvant radioiodine treatment in the past Patients with other cancer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>